Krishnan Nandabalan - Director, 10%+ Owner at BioXcel Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
BTAI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Krishnan Nandabalan since 11/22/2023

Holdings reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 8.55M $187M $21.89 Apr 6, 2023 Indirect
Stock Options 294K Apr 6, 2023 Direct Common Stock
Common Stock 0 $21.89 Apr 6, 2023 Direct

Transactions reported by Krishnan Nandabalan for BioXcel Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.